RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Background/Aims: Plug-assisted retrograde transvenous obliteration (PARTO) is widely used to manage gastric varices with a portosystemic shunt. It is not clear whether portal pressure and the incidence of complications increase after PARTO. The aim of this study was to determine the changes in portal pressure and the associated changes in liver function, ascites, hepatic encephalopathy, and especially esophageal varix (EV) after PARTO. Methods: From March 2012 to February 2018, 54 patients who underwent PARTO were analyzed retrospectively. The parameters collected included liver function and episodes of cirrhotic complications before and at 1 and 6 months after PARTO. Results: The analysis of 54 patients showed improvement in liver function during the 6-month follow-up period (Model for End-Stage Liver Disease score: change from 11.46±4.35 to 10.33±2.96, p=0.021).
Among these 54 patients, 25 patients were evaluated for their hepatic venous pressure gradient (HVPG) before and after PARTO (change from 12.52±3.83 to 14.68±5.03 mm Hg; p<0.001). Twenty-five patients with portal pressure measured before and after PARTO were evaluated for risk factors affecting liver function improvement and EV deterioration. No factor associated with portal pressure was affected by liver function improvement. Post-PARTO portal pressure was a risk factor affecting EV deterioration (HVPG-post: odds ratio, 1.341; 95% confidence interval, 1.017 to 1.767; p=0.037).
Conclusions: The artificial blockade of the portosystemic shunt evidently leads to an increase in HVPG. Liver function was improved over the 6-month follow-up period. Portal pressure after PARTO was a significant risk factor for EV deterioration.
Portal pressure measurement is helpful for predicting the patient’s clinical outcome.

참고문헌 (Reference)

1 Park JK, "Vascular plug-assisted retrograde transvenous obliteration of portosystemic shunts for refractory hepatic encephalopathy : a case report" 2014 : 391420-, 2014

2 Gwon DI, "Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy : a prospective multicenter study" 26 : 1589-1595, 2015

3 Kessler J, "Use of the Amplatzer Vascular Plug for embolization of a large retroperitoneal shunt during transjugular intrahepatic portosystemic shunt creation for gastric variceal bleeding" 17 : 135-140, 2006

4 Triantafyllou M, "Update on gastric varices" 6 : 168-175, 2014

5 Hong CH, "Treatment of patients with gastric variceal hemorrhage : endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration" 24 : 372-378, 2009

6 Kanagawa H, "Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration" 11 : 51-58, 1996

7 Park SJ, "The prevalence, risk factors, and clinical outcome of balloon rupture in balloonoccluded retrograde transvenous obliteration of gastric varices" 21 : 503-507, 2010

8 Hiraga N, "The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration" 42 : 663-672, 2007

9 Shimoda R, "Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension : effects of obliteration of major portosystemic shunts" 30 : 306-313, 2005

10 Yeon Seok Seo, "Prevention and management of gastroesophageal varices" 대한간학회 24 (24): 20-42, 2018